Blauvelt, A., Draelos, Z. D., Gooderham, M., Lain, E., Moore, A. Y., Papp, K. A., Zirwas, M., Krupa, D., Burnett, P., Berk, D. R., & Chu, D. H. (2023). Efficacy and Safety of Roflumilast Foam 0.3% in Patients With Seborrheic Dermatitis in a Phase 3 Trial: Assessment of Pruritus. SKIN The Journal of Cutaneous Medicine, 7(4), s226. https://doi.org/10.25251/skin.7.supp.226